title: Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti-CC chemokine receptor 4 antibody for the treatment of adult T-cell leukaemia/lymphoma.
authors.affiliation: Department of Internal Medicine, Hakodate Municipal Hospital, Hakodate, Japan.|Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
authors.forename: Souichi
authors.initials: S
authors.lastname: Shiratori
authors.affiliation: Department of Internal Medicine, Hakodate Municipal Hospital, Hakodate, Japan.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Ohhigashi
authors.affiliation: Department of Internal Medicine, Hakodate Municipal Hospital, Hakodate, Japan.
authors.forename: Shinichi
authors.initials: S
authors.lastname: Ito
authors.affiliation: Department of Clinical Pathology, Hakodate Municipal Hospital, Hakodate, Japan.
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Kudo
authors.affiliation: Department of Plastic and Reconstructive Surgery, Hakodate Municipal Hospital, Hakodate, Japan.
authors.forename: Maki
authors.initials: M
authors.lastname: Adachi
authors.affiliation: Department of Plastic and Reconstructive Surgery, Hakodate Municipal Hospital, Hakodate, Japan.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Minamimoto
authors.affiliation: Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
authors.forename: Junji
authors.initials: J
authors.lastname: Kato
authors.affiliation: Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
authors.forename: Yasue
authors.initials: Y
authors.lastname: Osai
authors.affiliation: Department of Internal Medicine, Hakodate Municipal Hospital, Hakodate, Japan.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tsutsumi
authors.affiliation: Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
authors.forename: Takanori
authors.initials: T
authors.lastname: Teshima
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000097:blood / Q000188:drug therapy*; D008297:Male; D054398:Receptors, CCR4 / Q000037:antagonists & inhibitors*; D013262:Stevens-Johnson Syndrome / Q000097:blood / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C515354:CCR4 protein, human; D054398:Receptors, CCR4; C549035:mogamulizumab